{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T02:02:32Z","timestamp":1793325752103,"version":"4.5.0"},"reference-count":25,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2014,12,28]],"date-time":"2014-12-28T00:00:00Z","timestamp":1419724800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Clin Exp Nephrol"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1007\/s10157-014-1078-7","type":"journal-article","created":{"date-parts":[[2014,12,27]],"date-time":"2014-12-27T14:57:13Z","timestamp":1419692233000},"page":"968-973","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":18,"title":["Exploring urinary biomarkers in autosomal dominant polycystic kidney disease"],"prefix":"10.1007","volume":"19","author":[{"given":"Haruna","family":"Kawano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoru","family":"Muto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasukazu","family":"Ohmoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fusako","family":"Iwata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroyuki","family":"Fujiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toyoki","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lu","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Horie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2014,12,28]]},"reference":[{"key":"1078_CR1","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1016\/S0140-6736(07)60601-1","volume":"369","author":"VE Torres","year":"2007","unstructured":"Torres VE, Harris PC, Pirson Y. Autosomal dominant polycystic kidney disease. Lancet. 2007;369:1287\u2013301.","journal-title":"Lancet"},{"key":"1078_CR2","doi-asserted-by":"crossref","first-page":"889","DOI":"10.2215\/CJN.00550110","volume":"5","author":"JJ Grantham","year":"2010","unstructured":"Grantham JJ, Cook LT, Wetzel LH, Cadnapaphornchai MA, Bae KT. Evidence of extraordinary growth in the progressive enlargement of renal cysts. Clin J Am Soc Nephrol. 2010;5:889\u201396.","journal-title":"Clin J Am Soc Nephrol"},{"key":"1078_CR3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000346812","volume":"37","author":"A Gianluca","year":"2013","unstructured":"Gianluca A, Luigi C, del Laura S. Multidrug therapy for polycystic kidney disease: a review and perspective. Am J Nephrol. 2013;37:175\u201382.","journal-title":"Am J Nephrol"},{"key":"1078_CR4","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/0092-8674(94)90137-6","volume":"77","author":"The European Polycystic Kidney Disease Consortium","year":"1994","unstructured":"The European Polycystic Kidney Disease Consortium. The polycystic kidney disease 1 gene encodes a 14\u00a0kb transcript and lies within a duplicates region on chromosome 16. Cell. 1994;77:881\u201394.","journal-title":"Cell"},{"key":"1078_CR5","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1126\/science.272.5266.1339","volume":"272","author":"T Mochizuki","year":"1996","unstructured":"Mochizuki T, Wu G, Hayashi T, Xenophontos SL, Veldhusen B, Saris JJ, et al. PKD2, agene for polycystic kidney disease that encodes an integral membrane protein. Science. 1996;272:1339\u201342.","journal-title":"Science"},{"key":"1078_CR6","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1042\/BST0350124","volume":"35","author":"S Qamar","year":"2007","unstructured":"Qamar S, Vadivelu M, Sandford R. TRP channels and kidney disease: lessons from polycystic kidney disease. Biochem Soc Trans. 2007;35:124\u20138.","journal-title":"Biochem Soc Trans"},{"key":"1078_CR7","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1038\/ncb1326","volume":"7","author":"X Li","year":"2005","unstructured":"Li X, Luo Y, Starremans PG, McNamara CA, Pei Y, Zhou J. Polycystin-1 and polycystin-2 regulate the cell cycle through the herix-loop-helix inhibitor Id2. Nat Cell Biol. 2005;7:1202\u201312.","journal-title":"Nat Cell Biol"},{"key":"1078_CR8","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1111\/j.1523-1755.2004.00843.x","volume":"66","author":"FA Belibi","year":"2004","unstructured":"Belibi FA, Reif G, Wallace DP, Yamaguchi T, Olsen L, Li H, et al. Cyclic AMP promotes growth and secretion in human polycystic kidney epithelial cells. Kidney Int. 2004;66:964\u201373.","journal-title":"Kidney Int"},{"key":"1078_CR9","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1681\/ASN.V1171179","volume":"11","author":"K Hanaoka","year":"2000","unstructured":"Hanaoka K, Guggino WB. cAMP regulates cell proliferation and cyst formation in autosomal polycystic kidney disease cells. J Am Soc Nephrol. 2000;11:1179\u201387.","journal-title":"J Am Soc Nephrol"},{"key":"1078_CR10","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1046\/j.1523-1755.2003.00023.x","volume":"63","author":"T Yamaguchi","year":"2003","unstructured":"Yamaguchi T, Nagao S, Wallace DP, et al. Cyclic AMP activates B-Raf and ERK in cyst epithelial cells from autosomal dominant polycystic kidneys. Kidney Int. 2003;63:1983\u201394.","journal-title":"Kidney Int"},{"key":"1078_CR11","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1038\/nm935","volume":"9","author":"VH Gattone 2nd","year":"2003","unstructured":"Gattone VH 2nd, Wang X, Harris PC, et al. Inhibition of renal cystic disease development and progression by a vasopressin V2 receptor antagonist. Nat Med. 2003;9:1323\u20136.18","journal-title":"Nat Med"},{"issue":"25","key":"1078_CR12","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1056\/NEJMoa1205511","volume":"367","author":"VE Torres","year":"2012","unstructured":"Torres VE, Chapman AB, Devuyst O, Gansevoort RT, Grantham JJ, Higashihara E, Perrone RD, Krasa HB, Ouyang J, Czerwiec FS, TEMPO 3:4 Trial Investigators. Tolvaptan in patients with autosomal dominant polycystic kidney disease. N Engl J Med. 2012;367(25):2407\u201318.","journal-title":"N Engl J Med"},{"issue":"4","key":"1078_CR13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s10157-011-0428-y","volume":"15","author":"S Tokiwa","year":"2011","unstructured":"Tokiwa S, Muto S, China T, Horie S. The relationship between renal volume and renal function in autosomal dominant polycystic kidney disease. Clin Exp Nephrol. 2011;15(4):539\u201345.","journal-title":"Clin Exp Nephrol"},{"issue":"10","key":"1078_CR14","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1097\/01.ASN.0000088027.54400.C6","volume":"14","author":"J Mishra","year":"2003","unstructured":"Mishra J, Ma Q, Prada A, Mitsnefes M, Zahedi K, et al. Identification of neutrophil gelatinase-associated lipocalin as a novel early urinary biomarker for ischemic renal injury. 2003. J Am Soc Nephrol. 2003;14(10):2534\u201343.","journal-title":"J Am Soc Nephrol"},{"issue":"4","key":"1078_CR15","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/BF03262209","volume":"16","author":"H Schiffl","year":"2012","unstructured":"Schiffl H, Lang SM. Update on biomarkers of acute kidney injury: moving closer to clinical impact? Mol Diagn Ther. 2012;16(4):199\u2013207.","journal-title":"Mol Diagn Ther"},{"issue":"8","key":"1078_CR16","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1038\/ki.2011.465","volume":"81","author":"RP Chirag","year":"2012","unstructured":"Chirag RP, Neera KD, Arlene C, James EB, Charles L, et al. Evaluation of urine biomarkers of kidney injury in polycystic kidney disease. Kidney Int. 2012;81(8):784\u201390.","journal-title":"Kidney Int"},{"issue":"7","key":"1078_CR17","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1681\/ASN.V17980","volume":"1","author":"H Takahashi","year":"1991","unstructured":"Takahashi H, Calvet JP, Dittemore-Hoover D, Yoshida K, Grantham JJ, Gattone VH 2nd. A hereditary model of slowly progressive polycystic kidney disease in the mouse. J Am Soc Nephrol. 1991;1(7):980\u20139.","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"1078_CR18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1538\/expanim.61.477","volume":"61","author":"S Nagao","year":"2012","unstructured":"Nagao S, Kugita M, Yoshihara D, Yamaguchi T. Animal models for human polycystic kidney disease. Exp Anim. 2012;61(5):477\u201388.","journal-title":"Exp Anim"},{"issue":"14","key":"1078_CR19","doi-asserted-by":"crossref","first-page":"10425","DOI":"10.1016\/S0021-9258(18)82217-7","volume":"268","author":"L Kjeldsen","year":"1993","unstructured":"Kjeldsen L, Johnsen AH, Sengelov H, Borregaard N. Isolation and primary structure of NGAL, a novel protein associated with human neutrophil gelatinase. J Biol Chem. 1993;268(14):10425\u201332.","journal-title":"J Biol Chem"},{"key":"1078_CR20","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(05)74811-X","volume":"365","author":"J Mishra","year":"2005","unstructured":"Mishra J, Dent C, Tarabishi R, Mitsnefes MM, Ma Q, et al. Neutrophil gelatine-associated lipocalin (NGAL) as a biomarker for acute renal injury after cardiac surgery. Lancet. 2005;365:1231\u20138.","journal-title":"Lancet"},{"issue":"1","key":"1078_CR21","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1002\/(SICI)1098-2795(199701)46:1<4::AID-MRD2>3.0.CO;2-V","volume":"46","author":"ER Stanley","year":"1997","unstructured":"Stanley ER, Berg KL, Einstein DB, Lee PS, Pixley FJ, et al. Biology and action of colony\u2014stimulating factor-1. Mol Reprod Dev. 1997;46(1):4\u201310.","journal-title":"Mol Reprod Dev"},{"issue":"3","key":"1078_CR22","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1038\/ki.1996.402","volume":"50","author":"Y Meur Le","year":"1996","unstructured":"Le Meur Y, Fixe P, Aldigier JC, Leroux-Robert C, Praloran V. Macrophage colony stimulating factor involvement in uremic patients. Kidney Int. 1996;50(3):1007\u201312.","journal-title":"Kidney Int"},{"issue":"7","key":"1078_CR23","doi-asserted-by":"crossref","first-page":"1862","DOI":"10.1093\/ndt\/gfh257","volume":"19","author":"Y Meur Le","year":"2004","unstructured":"Le Meur Y, Leprivey-Lorgeot V, Mons S, Jos\u00e9 M, Dantal J, et al. Serum levels of macrophage-colony stimulating factor (M-CSF): a marker of kidney allograft rejection. Nephrol Dial Transplant. 2004;19(7):1862\u20135.","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"1078_CR24","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1046\/j.1523-1755.2001.00065.x","volume":"60","author":"BD Cowley Jr","year":"2001","unstructured":"Cowley BD Jr, Ricardo SD, Nagao S, Diamond JR. Increased renal expression of monocyte chemoattractant protein-1 and osteopontin in ADPKD in rats. Kidney Int. 2001;60(6):2087\u201396.","journal-title":"Kidney Int"},{"issue":"10","key":"1078_CR25","doi-asserted-by":"crossref","first-page":"2588","DOI":"10.1097\/01.ASN.0000088720.61783.19","volume":"14","author":"D Zheng","year":"2003","unstructured":"Zheng D, Wolfe M, Cowley BD Jr, Wallace DP, Yamaguchi T, et al. Urinary excretion of monocyte chemoattractant protein-1 in autosomal dominant polycystic kidney disease. J Am Soc Nephrol. 2003;14(10):2588\u201395.","journal-title":"J Am Soc Nephrol"}],"container-title":["Clinical and Experimental Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-014-1078-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10157-014-1078-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10157-014-1078-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,25]],"date-time":"2022-04-25T13:49:22Z","timestamp":1650894562000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10157-014-1078-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,12,28]]},"references-count":25,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["1078"],"URL":"https:\/\/doi.org\/10.1007\/s10157-014-1078-7","relation":{},"ISSN":["1342-1751","1437-7799"],"issn-type":[{"value":"1342-1751","type":"print"},{"value":"1437-7799","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,12,28]]}}}